Clinic
Duke City Urgent Care
Duke City Urgent Care was paid $29.35M by Medicaid between Jan 2018 and Dec 2024, across 50 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoDUKE CITY URGENT CARE
ALBUQUERQUE, NM 87111
ALBUQUERQUE, NM 87111
33aNPI1790185577assigned 08/28/2014
33bProvider typeUrgent Care Clinic/Center
28Total paid$29.35M
24GClaims584,381
24DCodes billed50
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in New Mexico
Rank by total paid#1 of 26
Median peer was paid$1.29M
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,523 | $2.83M | |
| 2019 | 75,129 | $4.04M | |
| 2020 | 77,244 | $4.43M | |
| 2021 | 129,354 | $6.20M | |
| 2022 | 107,831 | $5.14M | |
| 2023 | 64,565 | $3.45M | |
| 2024incomplete | 89,735 | $3.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 107,824 | 105,948 | $10.15M |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 25% | 174,158 | 171,236 | $7.20M |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 20% | 45,509 | 44,701 | $6.01M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.2% | 26,899 | 26,250 | $950K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.1% | 11,670 | 11,474 | $913K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.8% | 5,059 | 4,992 | $818K |
| Q3014 | Telehealth originating site facility fee | 2.7% | 31,279 | 30,801 | $797K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.1% | 30,976 | 30,583 | $623K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.5% | 4,500 | 4,426 | $446K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 2,791 | 2,760 | $337K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16,624 | 16,415 | $241K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 5,226 | 5,176 | $232K |
38 more codes
| 99205 | Prolong outpt/office vis | <1% | 1,241 | $207K |
| 99051 | <1% | 19,619 | $98K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,683 | $91K |
| 81025 | <1% | 9,481 | $68K | |
| 81003 | <1% | 23,535 | $41K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,146 | $33K |
| 99000 | <1% | 7,739 | $30K | |
| S9083 | Global fee urgent care centers | <1% | 210 | $29K |
| 20552 | <1% | 339 | $13K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,324 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 288 | $6K |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 1,545 | $3K |
| 87301 | <1% | 261 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 152 | $1K |
| 93000 | <1% | 110 | $1K | |
| 80047 | <1% | 25 | $265.65 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 314 | $158.13 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 222 | $127.09 |
| 86580 | <1% | 21 | $113.54 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 83 | $105.81 |
| 85014 | <1% | 25 | $50.86 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 48 | $38.66 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 58 | $36.11 |
| 82962 | <1% | 13 | $33.52 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 12 | $26.35 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 40 | $5.09 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 28 | $2.54 |
| A9150 | Non-prescription drugs | <1% | 206 | $1.38 |
| 3008F | 0% | 17,289 | $0.00 | |
| 3075F | 0% | 1,402 | $0.00 | |
| 3079F | 0% | 2,870 | $0.00 | |
| 3080F | 0% | 1,852 | $0.00 | |
| 3074F | 0% | 7,563 | $0.00 | |
| 1125F | 0% | 12 | $0.00 | |
| 3077F | 0% | 2,092 | $0.00 | |
| 3078F | 0% | 6,552 | $0.00 | |
| 1160F | 0% | 1,423 | $0.00 | |
| 1159F | 0% | 3,043 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTALIAFERRO, EDWARD (PRESIDENT)